Lifeward Ltd (LFWD)

$6.58 -0.25 (-3.66%)
Market Cap 10.44M
Revenue (ttm) 22.03M
Net Income (ttm) -19.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -90.38%
Debt to Equity Ratio 0.33
Volume 17,600
Avg Vol 21,136
Day's Range N/A - N/A
Shares Out 1.53M
Stochastic %K 61%
Beta 0.16
Analysts Strong Sell
Price Target $10.00

Company Profile

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 959 0123
Address:
3 Hatnufa St., 6th floor P.O. Box 161, Yokneam Illit, Israel
_TannerTechnicals
_TannerTechnicals Apr. 8 at 11:07 AM
$LFWD $MWG $DSY $BTM jiggy
0 · Reply
Tannercharting
Tannercharting Apr. 8 at 8:48 AM
$TRNR $RPGL $LFWD $MWG []<
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 25 at 9:07 PM
$LFWD target for the next days?
2 · Reply
EvE12
EvE12 Mar. 25 at 8:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-successfully-closes-strategic-partnership-oramed
0 · Reply
Kjskms
Kjskms Mar. 25 at 11:27 AM
$LFWD South Korea's Samchundang Pharmaceutical makes it happen with oral insulin.
0 · Reply
Kjskms
Kjskms Mar. 24 at 12:05 PM
$LFWD How many decades have you been toying with the shareholders?
1 · Reply
NASDboy
NASDboy Mar. 23 at 5:25 PM
$LFWD comes free with your purchase!
0 · Reply
Kjskms
Kjskms Mar. 23 at 11:03 AM
$LFWD A stupid deficit company
0 · Reply
Kjskms
Kjskms Mar. 19 at 7:21 AM
$LFWD Sell ​​off all the failing businesses. What kind of stubbornness is this?
1 · Reply
mezquita
mezquita Mar. 18 at 3:14 PM
$LFWD The same thing every quarter: monkeys in charge of a company that could be incredible.
0 · Reply
Latest News on LFWD
Lifeward Successfully Closes on Strategic Partnership with Oramed

Mar 25, 2026, 4:10 PM EDT - 13 days ago

Lifeward Successfully Closes on Strategic Partnership with Oramed

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 18, 2026, 8:00 AM EDT - 21 days ago

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

Mar 13, 2026, 8:00 AM EDT - 26 days ago

Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

ORMP

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mar 11, 2026, 8:00 AM EDT - 4 weeks ago

Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Mar 10, 2026, 4:15 PM EDT - 4 weeks ago

Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Mar 2, 2026, 8:00 AM EST - 5 weeks ago

Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Feb 25, 2026, 8:00 AM EST - 5 weeks ago

Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

Lifeward Announces Reverse Share Split

Feb 20, 2026, 8:00 AM EST - 6 weeks ago

Lifeward Announces Reverse Share Split

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Feb 17, 2026, 8:00 AM EST - 7 weeks ago

Lifeward's ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Jan 13, 2026, 8:00 AM EST - 3 months ago

Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

ORMP

Oramed and Lifeward Announce Strategic Transaction

Jan 13, 2026, 7:58 AM EST - 3 months ago

Oramed and Lifeward Announce Strategic Transaction

ORMP

Lifeward Appoints Bob Marshall as Chairman of the Board

Dec 19, 2025, 4:05 PM EST - 3 months ago

Lifeward Appoints Bob Marshall as Chairman of the Board

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Dec 17, 2025, 8:00 AM EST - 3 months ago

Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

Dec 3, 2025, 8:00 AM EST - 4 months ago

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Nov 17, 2025, 8:00 AM EST - 5 months ago

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 8:00 AM EST - 5 months ago

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

Lifeward to Report Third Quarter Financial Results on November 14, 2025

Nov 10, 2025, 7:00 AM EST - 5 months ago

Lifeward to Report Third Quarter Financial Results on November 14, 2025

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Sep 9, 2025, 8:30 AM EDT - 7 months ago

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Sep 8, 2025, 8:30 AM EDT - 7 months ago

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 8:00 AM EDT - 8 months ago

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Aug 13, 2025, 8:00 AM EDT - 8 months ago

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Aug 7, 2025, 5:30 PM EDT - 8 months ago

Lifeward to Report Second Quarter Financial Results on August 14, 2025

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

Aug 4, 2025, 8:30 AM EDT - 8 months ago

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Jul 7, 2025, 11:00 AM EDT - 9 months ago

MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion

Lifeward Announces Closing of $2.6 Million Public Offering

Jun 26, 2025, 4:15 PM EDT - 10 months ago

Lifeward Announces Closing of $2.6 Million Public Offering

Lifeward Announces Pricing of $2.6 Million Public Offering

Jun 25, 2025, 9:10 AM EDT - 10 months ago

Lifeward Announces Pricing of $2.6 Million Public Offering

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Jun 24, 2025, 4:05 PM EDT - 10 months ago

Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary

Lifeward Names Mark Grant as New CEO

May 19, 2025, 8:30 AM EDT - 11 months ago

Lifeward Names Mark Grant as New CEO

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

May 19, 2025, 6:00 AM EDT - 11 months ago

Lifeward to Present at Sidoti Virtual Investor Conference on May 21

Lifeward Ltd. Reports First Quarter 2025 Financial Results

May 15, 2025, 8:00 AM EDT - 11 months ago

Lifeward Ltd. Reports First Quarter 2025 Financial Results

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

May 8, 2025, 8:30 AM EDT - 11 months ago

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

May 7, 2025, 4:30 PM EDT - 11 months ago

Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Apr 29, 2025, 8:30 AM EDT - 1 year ago

First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Apr 24, 2025, 8:30 AM EDT - 1 year ago

Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

Apr 15, 2025, 8:15 AM EDT - 1 year ago

Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market

FDA Issues Clearance for ReWalk 7 Exoskeleton

Mar 13, 2025, 9:15 AM EDT - 1 year ago

FDA Issues Clearance for ReWalk 7 Exoskeleton

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 7, 2025, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Mar 6, 2025, 8:00 AM EST - 1 year ago

Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Mar 5, 2025, 8:00 AM EST - 1 year ago

Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Feb 28, 2025, 8:00 AM EST - 1 year ago

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

Lifeward Announces CEO Transition

Feb 19, 2025, 9:10 AM EST - 1 year ago

Lifeward Announces CEO Transition

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Jan 13, 2025, 8:30 AM EST - 1 year ago

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Jan 13, 2025, 7:45 AM EST - 1 year ago

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 8, 2025, 4:15 PM EST - 1 year ago

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 7, 2025, 8:05 AM EST - 1 year ago

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Dec 27, 2024, 5:49 PM EST - 1 year ago

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Nov 19, 2024, 8:30 AM EST - 1 year ago

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 8:00 AM EST - 1 year ago

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Nov 5, 2024, 4:38 PM EST - 1 year ago

Lifeward to Report Third Quarter Financial Results on November 12, 2024

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

Oct 24, 2024, 4:30 PM EDT - 1 year ago

Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024

_TannerTechnicals
_TannerTechnicals Apr. 8 at 11:07 AM
$LFWD $MWG $DSY $BTM jiggy
0 · Reply
Tannercharting
Tannercharting Apr. 8 at 8:48 AM
$TRNR $RPGL $LFWD $MWG []<
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 25 at 9:07 PM
$LFWD target for the next days?
2 · Reply
EvE12
EvE12 Mar. 25 at 8:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-successfully-closes-strategic-partnership-oramed
0 · Reply
Kjskms
Kjskms Mar. 25 at 11:27 AM
$LFWD South Korea's Samchundang Pharmaceutical makes it happen with oral insulin.
0 · Reply
Kjskms
Kjskms Mar. 24 at 12:05 PM
$LFWD How many decades have you been toying with the shareholders?
1 · Reply
NASDboy
NASDboy Mar. 23 at 5:25 PM
$LFWD comes free with your purchase!
0 · Reply
Kjskms
Kjskms Mar. 23 at 11:03 AM
$LFWD A stupid deficit company
0 · Reply
Kjskms
Kjskms Mar. 19 at 7:21 AM
$LFWD Sell ​​off all the failing businesses. What kind of stubbornness is this?
1 · Reply
mezquita
mezquita Mar. 18 at 3:14 PM
$LFWD The same thing every quarter: monkeys in charge of a company that could be incredible.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 18 at 2:09 PM
$LFWD Q4 '25 Earnings Results & Recap Lifeward's Q4 2025 revenue decreased 33% to $5.1M, and GAAP net loss narrowed 65% to $5.3M from Q4 2024. Full year 2025 revenue declined 14% to $22M.
0 · Reply
Kjskms
Kjskms Mar. 18 at 1:40 PM
$LFWD I knew that would happen
0 · Reply
EvE12
EvE12 Mar. 18 at 1:19 PM
$LFWD Omg, Mark WTF? Where is Larry??
0 · Reply
EvE12
EvE12 Mar. 18 at 12:23 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-reports-fourth-quarter-and-full-year-2025-financial
0 · Reply
NASDboy
NASDboy Mar. 14 at 4:46 PM
$LFWD gurus on X , threads, and IG pumping this
1 · Reply
emailsl
emailsl Mar. 13 at 9:21 PM
$LFWD
0 · Reply
EvE12
EvE12 Mar. 13 at 12:51 PM
$LFWD https://ir.golifeward.com/news-releases/news-release-details/lifeward-receives-shareholder-approval-close-strategic
1 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD Target for the next weeks $50!
0 · Reply
HappyGentelmen
HappyGentelmen Mar. 13 at 12:20 PM
$LFWD News out! Rocket in the make!
0 · Reply
TheTradeXchange
TheTradeXchange Mar. 11 at 12:02 PM
$LFWD - Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 10 at 7:42 PM
$LFWD Share Price: $6.30 Contract Selected: Jul 17, 2026 $7.5 Calls Buy Zone: $0.42 – $0.52 Target Zone: $0.76 – $0.93 Potential Upside: 70% ROI Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
EvE12
EvE12 Mar. 8 at 11:50 AM
$LFWD The Oramed deal should contribute to the removal of the going-concern warning at LFWD, which should eventually bear fruit and serve as a catalyst.
1 · Reply